Department of Child and Adolescent Psychiatry, Hassenfeld Children's Hospital at NYU Langone.
Department of Psychology, Temple University.
J Consult Clin Psychol. 2018 Sep;86(9):738-750. doi: 10.1037/ccp0000334.
To report functional outcomes from the multisite Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), which examined the impact of youth anxiety treatment (cognitive-behavioral therapy [CBT], coping cat; Sertraline, SRT; COMB [CBT + SRT]; pill placebo) on (a) global and (b) domain-specific functioning assessed an average of 3.1 times, 3- to 12-years postrandomization (first assessment = mean 6.5 years postrandomization).
Three-hundred and 19 of 488 families from the Child/Adolescent Anxiety Multimodal Study (CAMS; Walkup et al., 2008) participated. Growth curve modeling examined the impact of treatment condition and acute treatment outcomes (i.e., response, remission) on global functioning, global and domain-specific impairment, and life satisfaction across follow-up visits. Logistic regressions explored the impact of treatment remission and condition on low frequency events (arrests/convictions) and education.
Treatment responders and remitters demonstrated better global functioning, decreased overall impairment, and increased life satisfaction at follow-up. Treatment remission, but not response, predicted decreased domain-specific impairment (social relationships, self-care/independence, academic functioning), and maintenance of increased life satisfaction across follow-ups. Participants in the CBT condition, compared with pill placebo, demonstrated improved trajectories pertaining to life satisfaction, overall impairment, and impairment in academic functioning. Randomization to CBT or COMB treatment was associated with increasing employment rates. Trajectories for participants randomized to SRT was not significantly different from placebo. Treatment outcome and condition did not predict legal outcomes, school/work variables, or family life.
Positive early intervention outcomes are associated with improved overall functioning, life satisfaction, and functioning within specific domains 6.5 years posttreatment. Treatment type differentially predicted trajectories of functioning. Findings support the positive impact of pediatric anxiety treatment into adolescence and early adulthood. (PsycINFO Database Record
报告多地点儿童/青少年焦虑多维扩展长期研究(CAMELS)的功能结果,该研究考察了青少年焦虑治疗(认知行为疗法[CBT]、应对猫;舍曲林,SRT;COMB[CBT+SRT];安慰剂丸)对(a)总体和(b)特定领域功能的影响,平均评估了 3.1 次,随机分组后 3 至 12 年(第一次评估=随机分组后平均 6.5 年)。
来自儿童/青少年焦虑多维研究(CAMS;Walkup 等人,2008)的 488 个家庭中有 319 个家庭参与了该研究。增长曲线模型考察了治疗条件和急性治疗结果(即反应、缓解)对整体功能、整体和特定领域障碍以及生活满意度的影响。逻辑回归探索了治疗缓解和条件对低频事件(逮捕/定罪)和教育的影响。
治疗反应者和缓解者在随访中表现出更好的整体功能、整体障碍减少和生活满意度提高。治疗缓解,而不是反应,预测了特定领域障碍(社会关系、自我护理/独立、学业功能)的减少,并维持了整个随访期间生活满意度的增加。与安慰剂丸相比,CBT 组的参与者在生活满意度、整体障碍和学业功能障碍方面表现出改善的轨迹。随机分配到 CBT 或 COMB 治疗与增加的就业率相关。随机分配到 SRT 的参与者的轨迹与安慰剂无显著差异。治疗结果和条件与法律结果、学校/工作变量或家庭生活无关。
早期积极干预结果与治疗后 6.5 年总体功能、生活满意度和特定领域功能的改善相关。治疗类型不同地预测了功能轨迹。研究结果支持儿童期焦虑症治疗对青春期和成年早期的积极影响。